A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon (R)) as a structure modifying therapy in osteoarthritis of the hip and knee
K. Pavelka et al., A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon (R)) as a structure modifying therapy in osteoarthritis of the hip and knee, OSTEO CART, 8(5), 2000, pp. 335-342
Objective: To determine the structure (disease) modifying effect of a glyco
saminoglycan polypeptide association complex (GP-C; Rumalon(R)) in patients
with knee and hip osteoarthritis (OA).
Methods: Double-blind, randomized, placebo-controlled five-year study. Prim
ary assessment criterion was change in radiographic joint space width betwe
en baseline and follow-up at 5 years. Secondary outcome criteria included L
equesne algofunctional index (LAI), pain on passive motion and consumption
of non-steroidal antiinflammatory drugs (NSAIDs). The patients received 10
courses of injections of placebo or GP-C 2 mi intramuscularly in 5 years (t
wo courses each year). Each course included 15 injections administered twic
e weekly.
Results: There were 277 patients with knee OA and 117 patients with hip OA.
Control and GP-G treated groups were comparable as to sex, age, duration o
f disease, body weight, X-ray stage and value of LAI at the baseline. Knee
joint space at 5 years decreased 0.37+/-0.08 (mean+/-standard deviation) mm
for GP-C and 0.42+/-0.08 mm for placebo groups (P=0.68). Hip joint space a
t 5 years decreased 0.21+/-0.08 mm for GP-C and 0.22+/-0.08 mm for placebo
groups (P=0.53). In a subset of patients with hip OA, Kellgren-Lawrence gre
ater than or equal to 2 and JSW greater than or equal to 1 mm, there was a
trend in favor of GPC for lower joint space narrowing in 5 years (P=0.11).
In addition, there were no statistical differences between the treatment gr
oups in LAI, pain on passive motion and consumption of NSAIDs. Side-effects
after GP-C (14.5%) were rare, mild and not more frequent than in the place
bo group (15%).
Conclusion: We were not able to demonstrate a structure modifying effect of
GP-C in OA of the hip or knee. Radiographic progression of OA in both knee
and hip OA was lower than expected in both study groups. (C) 2000 OsteoArt
hritis Research Society International.